{
    "organizations": [],
    "uuid": "28fa817dc23339be31c25941c40b31b96b1baac6",
    "author": "",
    "url": "https://www.reuters.com/article/brief-htg-molecular-diagnostics-inc-says/brief-htg-molecular-diagnostics-inc-says-on-march-30-2018-co-and-qiagen-manchester-limited-entered-second-amendment-of-first-statement-of-work-idUSFWN1RH0MW",
    "ord_in_thread": 0,
    "title": "BRIEF-HTG Molecular Diagnostics Inc Says On March 30, 2018, Co And Qiagen Manchester Limited Entered Second Amendment Of First Statement Of Work",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 5 (Reuters) - HTG Molecular Diagnostics Inc\n* HTG MOLECULAR DIAGNOSTICS INC - ON MARCH 30, 2018, CO AND QIAGEN MANCHESTER LIMITED ENTERED SECOND AMENDMENT OF FIRST STATEMENT OF WORK - SEC FILING\n* HTG MOLECULAR DIAGNOSTICS INC - QIAGEN HAS AGREED TO PAY COMPANY LOW, SINGLE-DIGIT MILLIONS OF DOLLARS IN DEVELOPMENT FEES FOR NEXT-PHASE ACTIVITIES\n* HTG- QIAGEN ALSO AGREED TO PAY CO MILESTONE UPTO AMOUNT IN LOW,SINGLE-DIGIT MLN OF DOLLARS ON ACHIEVEMENT OF SOME MILESTONES IN NEXT-PHASE ACTIVITIES\n* HTG MOLECULAR DIAGNOSTICS INC - THE NEXT-PHASE ACTIVITIES ARE EXPECTED TO BE COMPLETED IN Q2 OF 2018 Source text: ( bit.ly/2GZwjMW ) Further company coverage:\n ",
    "published": "2018-04-05T00:27:00.000+03:00",
    "crawled": "2018-04-05T00:44:53.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "htg",
        "molecular",
        "diagnostics",
        "inc",
        "htg",
        "molecular",
        "diagnostics",
        "inc",
        "march",
        "co",
        "qiagen",
        "manchester",
        "limited",
        "entered",
        "second",
        "amendment",
        "first",
        "statement",
        "work",
        "sec",
        "filing",
        "htg",
        "molecular",
        "diagnostics",
        "inc",
        "qiagen",
        "agreed",
        "pay",
        "company",
        "low",
        "million",
        "dollar",
        "development",
        "fee",
        "activity",
        "qiagen",
        "also",
        "agreed",
        "pay",
        "co",
        "milestone",
        "upto",
        "amount",
        "low",
        "mln",
        "dollar",
        "achievement",
        "milestone",
        "activity",
        "htg",
        "molecular",
        "diagnostics",
        "inc",
        "activity",
        "expected",
        "completed",
        "q2",
        "source",
        "text",
        "company",
        "coverage"
    ]
}